GLOBAL OPIOIDS DRUG MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL OPIOIDS DRUG MARKET FORECAST 2019-2027

GLOBAL OPIOIDS DRUG MARKET FORECAST 2019-2027

The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027. Opioids are narcotic drugs and mostly directed for pain management. The drugs act on both the central nervous system and peripheral nervous system. The following factors primarily drive the opioids drugs market:

GLOBAL OPIOIDS DRUG MARKET FORECAST 2019-2027

Global Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief), & by Geography.

Request free sample

The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027. Opioids are narcotic drugs and mostly directed for pain management. The drugs act on both the central nervous system and peripheral nervous system. The following factors primarily drive the opioids drugs market:

  • Increasing road accidents and surgical procedures
  • Escalating palliative care for patients suffering intensely
  • Usage of abuse-deterrent formulations to restrict the opioid abuse
  • Growing occurrence of chronic pain

The important drivers that are proliferating the global opioids drugs market are increasing road accidents & surgical procedures, and usage of abuse-deterrent formulations to restrict the opioid abuse. The opioid drugs are commonly used in relieving the pain from post-operative surgical procedures. FDA has approved opioid with ADF labeling and is currently marketed in the U.S.

The applications of opioids drugs market are very extensive for various purposes. Opioids are used for pain management during cancer treatment, owing to various advantages associated with it, for instance, compatibility with chemotherapy drugs, multiple routes of administration, and effectiveness in all types of pain, including neuropathic, visceral and somatic. Opioids are the gold standard when used as an anesthetic in invasive surgical procedures. Opioids effectively activate intestinal receptors to create constipation effect. They are also used for postsurgical pain management.

Increase in their adoption in the treatment of neuropathic pain can mainly be attributed to the benefits of opioids, such as higher efficacy over lower dosage, over tricyclic antidepressants and gabapentin. Rehabilitation centers commonly use methadone and buprenorphine to gradually decrease the dependency of individuals on addictive opioids, like morphine and heroin.

Misuse of opioids and the consequential stringent regulatory framework are the major factors hindering the opioids drugs market. The misuse and addiction towards opioid drugs are one of the serious public health concerns. The U.S. FDA is strictly regulating the opioids market due to a significant number of deaths registered in the country owing to drug abuse.

The global opioids drugs market segments include products and applications.

Products are sub-segmented into:

  • Buprenorphine
  • Fentanyl
  • Hydrocodone
  • Morphine
  • Oxycodone
  • Tramadol
  • Other products

Applications are sub-segmented into:

    • Pain relief
      • Cancer pain
      • Postoperative pain management
      • Low back pain
      • Orthopedic
      • Neuropathic
      • Fibromyalgia
    • Anesthesia
    • Cough suppression
    • Diarrhea suppression
    • Deaddiction

This report covered the present market conditions and the growth prospects of the global opioids drugs market for 2019-2027 forecast period and considered the revenue generated through the sales of opioids drugs by products and applications to calculate the market size by considering 2018 as the base year.

Geographically, the global opioids drugs market has been segmented on the basis of four major regions, which include:

The opioids drugs market in North America is expected to hold the largest share by 2027 possibilities of growing prevalence of disease conditions with chronic pain, including arthritis, cancer, fibromyalgia, lower back pain, trauma and postsurgical pain. The repeatedly increasing geriatric population prone to irreversible and incurable conditions is enhancing the demand for pain management treatments in the market.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the opioids drugs market. The rising prevalence of cancer and chronic pain, growing surgical procedures and investments from local and regional players in the development of abuse-deterrent morphine drug are the factors attributed for a high growth rate of the opioid drug market in the Asia Pacific region. The growing prevalence of chronic pain and strict attitudes towards prescription of opioids for medical application are the factors attributed to the moderate growth rate of opioid drugs in Japan.

The opioids drugs market is segmented based on products which are sub-divided into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, tramadol and other products. Buprenorphine is a partial agonist and interacts with the mu-opioid receptor. The market of fentanyl is anticipated to grow at a moderate rate during the forecast period. Hydrocodone is a semi-synthetic opioid most thoroughly associated with codeine in structure and morphine in manufacturing opiate-like properties. Morphine is a naturally arising phenanthrene derivative and used as a typical drug against which all additional opioids are associated. Oxycodone is a schedule II narcotic, indicated for the management of acute, chronic, moderate to severe pain where the use of an opioid analgesic is found to be appropriate. Tramadol is a centrally acting analgesic with opioid and non-opioid mechanisms of action. Tapentadol is a newer analgesic acting as an agonist at the mu-opioid receptor and as a norepinephrine reuptake inhibitor.

The major market players of the global opioids drugs market are:

  • Janssen Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Collegium Pharmaceutical, Inc.
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Limited

Janssen Pharmaceuticals, Inc. provides pharmaceutical and consumer products. The pharmaceuticals division consists of an array of drugs management for neurological conditions, cancer, pain, and autoimmune diseases. The consumer healthcare (CHC) business division of Sun Pharmaceutical Industries Limited develops and markets over-the-counter (OTC) products in India. Sun Pharma’s OTC brands include Revital, Revital Liquid, Revital Woman, Revital Senior, Revitalite, Volini Gel, Volini Spray, Volini Active Gel, Chericof Cough Syrup, Pepfiz, Garlic Pearls and Olesan Oil.

Key Findings of the global opioids drugs market:

  • Oxycodone holds the largest market share in terms of product
  • Anesthesia is the majorly used application
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • OXYCODONE HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
      • ANESTHESIA IS THE MAJORLY USED APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
      • ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
      • USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
      • GROWING OCCURRENCE OF CHRONIC PAIN
    • MARKET RESTRAINTS
      • MISUSE OF OPIOIDS
      • STRINGENT REGULATORY FRAMEWORK
    • MARKET OPPORTUNITIES
      • INCREASING USE OF EXTENDED-RELEASE OPIOID FORMULATIONS
      • WIDE RANGE OF APPLICATIONS OF OPIOIDS IN THE THERAPEUTIC MANAGEMENT
    • MARKET CHALLENGES
      • INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
      • RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • REGULATORY FRAMEWORK
    • PIPELINE ANALYSIS
    • INDUSTRY EVENTS IN OPIOID DRUGS MARKET
    • TECHNOLOGIES ADVANCEMENT
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ACURA PHARMACEUTICALS, INC.
      • ALLERGAN PLC
      • BIODELIVERY SCIENCES INTERNATIONAL, INC.
      • CIPHER PHARMACEUTICALS INC.
      • COLLEGIUM PHARMACEUTICAL, INC.
      • DAIICHI SANKYO, INC.
      • EGALET
      • HIKMA PHARMACEUTICALS PLC
      • INDIVIOR INC.
      • INSYS THERAPEUTICS, INC.
      • JANSSEN PHARMACEUTICALS, INC.
      • JOHNSON & JOHNSON
      • LANNETT CO. INC.
      • LUPIN LTD.
      • MYLAN NV
      • PFIZER INC.
      • PURDUE PHARMA LP
      • SANOFI-AVENTIS S.A.
      • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.

LIST OF TABLES

TABLE 1       GLOBAL OPIOIDS DRUG MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2       ANESTHETIC EFFECTS OF DRUGS AT DIFFERENT OPIOID RECEPTORS

TABLE 3       FDA APPROVED OPIOIDS WITH ADF LABELLING

TABLE 4       NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES 2015–2027

TABLE 5       GLOBAL OPIOIDS DRUGS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 6       GLOBAL BUPRENORPHINE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 7       GLOBAL FENTANYL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8       GLOBAL HYDROCODONE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 9       GLOBAL MORPHINE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10     GLOBAL OXYCODONE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 11     GLOBAL TRAMADOL MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 12     GLOBAL OTHER PRODUCTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13     GLOBAL OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14     GLOBAL OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 15     GLOBAL PAIN RELIEF MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 16     GLOBAL PAIN RELIEF MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 17     GLOBAL CANCER PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 18     GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 19     GLOBAL LOW BACK PAIN MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 20     GLOBAL ORTHOPEDIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 21     GLOBAL NEUROPATHIC MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 22     GLOBAL FIBROMYALGIA MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 23     GLOBAL ANESTHESIA MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24     GLOBAL COUGH SUPPRESSION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 25     GLOBAL DIARRHEA SUPPRESSION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 26     GLOBAL DEADDICTION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 27     LIST OF ER/LA OPIOID BRANDED DRUGS 2017

TABLE 28     LISTS OF ER/LA OPIOID GENERIC DRUGS 2017

TABLE 29     CDC GUIDELINES ON PRESCRIBING OPIOIDS

TABLE 30     PIPELINE ANALYSES OF OPIOID DRUGS

TABLE 31     GLOBAL OPIOIDS DRUGS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 32     NORTH AMERICA OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 33     NUMBER OF OPIOIDS PRESCRIPTIONS IN CANADA 2015-2016 (MILLIONS)

TABLE 34     EUROPE OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 35     ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 36     REST OF THE WORLD OPIOIDS DRUGS MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1     GLOBAL OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

FIGURE 2     NUMBER OF DEATHS IN THE UNITED STATES DUE TO DRUG OVERDOSE 2010–2016

FIGURE 3     GLOBAL OPIOIDS DRUGS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE 4     GLOBAL OPIOIDS DRUGS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 5     PORTER’S FIVE FORCE MODEL

FIGURE 6     GLOBAL OPIOIDS DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 7     THE UNITED STATES OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 8     NUMBER OF OPIOID PRESCRIPTIONS DISPENSED IN THE UNITED STATES 2015-2017 (MILLIONS)

FIGURE 9     NUMBER OF DRUG OVERDOSE DEATHS IN THE UNITED STATES 2010-2016

FIGURE 10   CANADA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 11   GERMANY OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 12   FRANCE OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 13   THE UNITED KINGDOM OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 14   SPAIN OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 15   ITALY OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 16   REST OF EUROPE OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 17   JAPAN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 18   CHINA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 19   INDIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 20   AUSTRALIA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 21   SOUTH KOREA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 22   REST OF ASIA PACIFIC OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 23   LATIN AMERICA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 24   MIDDLE EAST AND AFRICA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 25   OPIOIDS MARKET POSITION ANALYSIS 2017

  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now